Navigation Links
Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients

Patients who undergo lung transplants suffer from rejection of the organ. Hence according to a study researchers have found that inhaled anti-rejection drug, cyclosporine significantly reduces// rejection and results in better lung function. The study results were presented at the American Thoracic Society International Conference. The findings come from the same study that previously found that inhaled cyclosporine improved survival and extended periods of chronic rejection-free survival in lung transplant patients. Those results were published in The New England Journal of Medicine in January 2006. ‘Many lung transplant patients develop chronic rejection of the new lung—it is the Achilles heel of the transplant process,’ said lead researcher Aldo Iacono, M.D., Medical Director of Lung Transplantation at the University of Maryland in Baltimore.

‘Typically, patients experience a progressive, inexorable decline in lung function, most likely because of this chronic rejection and infections. This finding that aerosolized cyclosporine preserves lung function bolsters our previous findings that the drug reduces chronic rejection of the lung.’ The new study looked at 58 lung transplant patients, who were randomly assigned to inhale either 300 mg of aerosol cyclosporine or aerosol placebo three days a week for the first two years after their transplant. Both groups received oral anti-rejection medicines.

Patients who received the placebo experienced a decline in lung function that was four times as great as those who inhaled the cyclosporine. There was no difference in the rate of acute rejection of the lung (rejection occurring in the first few weeks after surgery) between the two groups. ‘Since the early 1990s we have been studying inhaled cyclosporine in lung transplant patients after they experience chronic rejection, but this is the first trial in which inhaled cyclosporine was used soon after the lung transplant occurred, before chronic rejection
'"/>




Page: 1 2

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
3. The Effectiveness Of Inhaled Corticosteroids Studied
4. The Effectiveness Of Inhaled Corticosteroids Studied
5. Inhaled nitric oxide therapy does not reduce death risk of infants
6. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
7. HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy
8. Inhaled Insulin To Be Made Available in India
9. Inhaled Insulin Could Rock The Drug Market Soon
10. High Cost Forces NHS To Reject Inhaled Insulin
11. Inhaled Insulin: A New Modality for Management of Diabetes

Post Your Comments:
(Date:12/2/2009)... Award-winning author James A. Feinst...ook, Short White Coat: Lessons from Patients on Be... the third year of medical school--the grueling cl...IA, PA (PRWEB) December 2, 2009 -- Most people wi...es dressed in a tiny hospital gown or staring at s...
(Date:12/2/2009)... SAN DIEGO, Dec. 2 Gen-P... the 21st Annual Piper Jaffray Health Care Confere...ion is scheduled to be webcast live and may be acc...en-Probe,s website at www.gen-probe.com . The web...vent. ,, About Gen-Probe ,, Gen-Probe Inc...
(Date:12/2/2009)... JOHANNESBURG, Dec. 2 LeapFrog Inv... million) investment in AllLife, the innovative So... and diabetes. The investment brings together Leap...and AllLife, one of Africa,s most innovative insur... World AIDS Day. ,, "AllLife has developed a di...
(Date:12/2/2009)...esults of a large-scale clinical trial presented t...iety of North America (RSNA) provide the first str...trasound for women with dense breasts who are at e...tudy confirmed that MRI is highly sensitive in dep...ual screening with ultrasound in addition to mammo...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, The Future o...arket Forecasts to 2015, Competitive Benchmarking,...//www.reportlinker.com/p0166814/The-Future-of-Cent...Forecasts-to-2015-Competitive-Benchmarking-Product...
Breaking Medicine News(10 mins):Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
...://www.EvasVillage.org ), a comprehensive New Jers...se in need in 2009, and a decline in foundation gr...on, New Jersey, seeks additional funding to meet t...grams and a decline in foundation grants and gift...
...portunities for improvement amidst high satisfacti...ocus) May 27, 2009 -- Nursing home consumer satisf...hile workforce satisfaction is at its highest leve...nt research firm My InnerView shows a majority (...
... sector can play a leadership role in reducing the...educing its climate footprint. These efforts, som...e the serious health threats posed by global warmi... Without Harm. , , "By reducing its climate footp...
...ked together to develop a computer model to help a...influenza. The tool can help estimate false negati...reening process, and so assess the risk of infecte...hland, Washington, and teams at Oak Ridge National...
...Central Valley , , MOUNTAIN VIEW, Calif., May 26 ...nd leading providers of kidney dialysis services a...nnounced their participation at the National Kidne... Satellite Healthcare,s commitment to kidney healt...
...for four hours before they allowed him to enter th...ingerprints to disappear. His oncologist is now ad...ith the commonly used drug, capecitabine, to carry... [1], published online today (Wednesday 27 May). A...
Other Medicine News:Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 2Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 3Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 4Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 5Health News:Nursing Home Consumer, Workforce Satisfaction Reaches New Highs 2Health News:World Health Organization Says Health Sector Can Lead the Fight Against Climate Change 2Health News:Pandemic passenger screening 2Health News:Satellite Healthcare Walks for Kidney Health 2Health News:Cancer drug causes patient to lose fingerprints and be detained by US immigration 2
(Date:12/1/2009).... 1 Former New Jersey As...ed when his radiotherapy treatment sessions for pr...to less than five. Midway through his course of t...Cancer Center acquired the region,s first Rapid...ical Systems (NYSE: VAR ), making it possible fo...
(Date:12/1/2009)... 1 The educational resou...mproving Life," created by Lilly USA (NYSE: LLY ...om/value_of_medicine.jsp . The booklet supports Li..." and encourages an open dialogue with patients, p...al industry practices. ,, "Today, Lilly and ot...
(Date:12/1/2009)...tCall/ -- WebMD Health Corp. (Nasdaq: WBMD ), the...nced the honorees of the 2009 WebMD Health Heroes ...r Americans with extraordinary stories of personal...elp others achieve better health. ,, (Photo...Y18114 ) ,, "WebMD is honoring its 2009 Health...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 31 scan per patient is not always enough 59758 11 scan per patient is not always enough 59758 2Catching a killer one spore at a time 10417 1Catching a killer one spore at a time 10417 2PETAs push for changes in USDA testing pays off for animals 10415 1
...iles Additional Data to the NEBIDO NDA ...XINGTON, Mass., Jan. 22 Indevus,Pharmaceuticals, ...ositive,results from its Phase III program for NEB...ctable testosterone therapy under development for ... announced today has been,filed with the U.S. Food...
... Trial to Evaluate Anti-Tumor Activity of Bavituxi...nd Paclitaxel-, TUSTIN, Calif., Jan. 22 Peregrin...al stage biopharmaceutical,company developing mono...hepatitis C virus (HCV) infection, today announced...tuximab in combination with chemotherapy in,patien...
Other Medicine Technology:Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 2Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 3Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 4Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 5Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 6Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4
iRISystem
WatchMate LC
...gical Services is a Web-based and RFID-enabled loc... measure patient flow and utilization of resources...ion to discharge. AgileTrac collects patient infor...delays your patient might experience. This informa...
AgileTrac™ Patient Flow
Medicine Products: